Literature DB >> 26764285

Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results.

Solvej Lippert1, Kasper D Berg1, Gunilla Høyer-Hansen2,3, Ida K Lund2,3, Peter Iversen1, Ib J Christensen2,3, Klaus Brasso1, Martin A Røder1.   

Abstract

AIM: Urokinase plasminogen activator receptor (uPAR) plays a central role during cancer invasion by facilitating pericellular proteolysis. We initiated the prospective 'Copenhagen uPAR Prostate Cancer' study to investigate the significance of uPAR levels in prostate cancer (PCa) patients.
METHODS: Plasma samples and clinical data from patients with newly diagnosed PCa have been collected prospectively. The uPAR forms have been measured in plasma using time-resolved fluorescence immunoassays.
RESULTS: The level of intact uPAR(I-III) did not differ. Plasma uPAR(I-III) + uPAR(II-III) levels and uPAR(I) levels were significantly higher in hormone-naive and castrate-resistant patients compared with patients with localized disease (both: p < 0.0001).
CONCLUSION: Our results show that cleaved uPAR forms are significantly increased in patients with advanced PCa.

Entities:  

Keywords:  prostate cancer; uPA; uPAR; urokinase plasminogen activator receptor

Mesh:

Substances:

Year:  2016        PMID: 26764285     DOI: 10.2217/bmm.15.114

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  5 in total

1.  Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer.

Authors:  Larry Fliegel
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 2.  The Cohesive Metastasis Phenotype in Human Prostate Cancer.

Authors:  William L Harryman; James P Hinton; Cynthia P Rubenstein; Parminder Singh; Raymond B Nagle; Sarah J Parker; Beatrice S Knudsen; Anne E Cress
Journal:  Biochim Biophys Acta       Date:  2016-09-24

Review 3.  Oncolytic virotherapy for urological cancers.

Authors:  Zahid Delwar; Kaixin Zhang; Paul S Rennie; William Jia
Journal:  Nat Rev Urol       Date:  2016-05-24       Impact factor: 14.432

Review 4.  PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectives.

Authors:  Dorthe Skovgaard; Morten Persson; Andreas Kjaer
Journal:  Clin Transl Imaging       Date:  2016-07-04

5.  Roles of the Na+/H+ Exchanger Isoform 1 and Urokinase in Prostate Cancer Cell Migration and Invasion.

Authors:  Xiuju Li; Benjamin Buckley; Konstantin Stoletov; Yang Jing; Marie Ranson; John D Lewis; Mike Kelso; Larry Fliegel
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.